GENE ONLINE|News &
Opinion
Blog

Generic Drug
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
If It Works, Replicate It: Generic COVID-19 Drugs
2022-03-28
First Generic for Dry-eye Gets U.S. FDA Nod
2022-02-04
China Drugmaker Aims for First Generic Drug Approval of Novartis’ Tasigna in China
2021-09-24
Mainstream Generic Drugs Become Stumbling Blocks for Drug Innovation: A Deepdive into China’s Patent Trends
2021-03-17
Perrigo Splits Businesses, Offloads Generic Division to Private Equity
2021-03-04
Taiwan’s TTY Biopharm Pushes for Clinical Trials of its Complex Cancer Generic Drugs in Europe
2021-02-10
LATEST
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
Unveiling the Role of Microbes in Climate Change at COP28
2023-12-04
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
EVENT
Scroll to Top